181 |
|
182 |
|
183 |
|
184 |
|
185 |
|
186 |
|
187 |
|
188 |
|
189 |
|
190 |
Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Khandavilli S, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P and Moore T..
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Methods and Findings in Experimental and Clinical Pharmacology 2004,
|
191 |
Ramachandran U and Sharma M..
. The Pharma Review 2004,
|
192 |
|
193 |
|
194 |
|
195 |
|